Jubilant Ingrevia Gelecekteki Büyüme
Future kriter kontrolleri 4/6
Jubilant Ingrevia is forecast to grow earnings and revenue by 33.1% and 14.8% per annum respectively. EPS is expected to grow by 33% per annum. Return on equity is forecast to be 11.8% in 3 years.
Anahtar bilgiler
33.1%
Kazanç büyüme oranı
33.0%
EPS büyüme oranı
| Chemicals kazanç büyümesi | 21.0% |
| Gelir büyüme oranı | 14.8% |
| Gelecekteki özkaynak getirisi | 11.8% |
| Analist kapsamı | Low |
| Son güncelleme | 24 Oct 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Kazanç ve Gelir Büyüme Tahminleri
| Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
|---|---|---|---|---|---|
| 3/31/2027 | 59,807 | 4,330 | 2,571 | 6,491 | 3 |
| 3/31/2026 | 53,037 | 3,427 | -3,102 | 5,277 | 3 |
| 3/31/2025 | 45,723 | 2,539 | -979 | 6,239 | 3 |
| 9/30/2024 | 41,104 | 1,755 | 2,074 | 6,831 | N/A |
| 6/30/2024 | 40,851 | 1,740 | N/A | N/A | N/A |
| 3/31/2024 | 41,358 | 1,829 | -1,384 | 4,300 | N/A |
| 12/31/2023 | 42,063 | 2,059 | N/A | N/A | N/A |
| 9/30/2023 | 43,982 | 2,589 | -2,051 | 3,901 | N/A |
| 6/30/2023 | 46,819 | 2,857 | N/A | N/A | N/A |
| 3/31/2023 | 47,727 | 3,075 | -189 | 4,625 | N/A |
| 12/31/2022 | 49,235 | 3,238 | N/A | N/A | N/A |
| 9/30/2022 | 50,516 | 3,613 | -42 | 3,191 | N/A |
| 6/30/2022 | 49,706 | 3,878 | N/A | N/A | N/A |
| 3/31/2022 | 49,494 | 4,767 | 2,226 | 4,527 | N/A |
| 3/31/2021 | 6,841 | 544 | 847 | 1,123 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: 543271's forecast earnings growth (33.1% per year) is above the savings rate (6.7%).
Kazançlar ve Piyasa: 543271's earnings (33.1% per year) are forecast to grow faster than the Indian market (18.1% per year).
Yüksek Büyüme Kazançları: 543271's earnings are expected to grow significantly over the next 3 years.
Gelir ve Pazar: 543271's revenue (14.8% per year) is forecast to grow faster than the Indian market (10.2% per year).
Yüksek Büyüme Geliri: 543271's revenue (14.8% per year) is forecast to grow slower than 20% per year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: 543271's Return on Equity is forecast to be low in 3 years time (11.8%).